Introduction
Solitary cysticercus granuloma is a common imaging finding in Indian patients with focal and generalized seizures. [1] [2] [3] [4] These lesions are reported to be the cause of seizures in up to 50% of Indian patients presenting with partial seizures. 5, 6 Many authors in India have described spontaneous resolution of solitary cysticercus granuloma. [6] [7] [8] The time of spontaneous resolution, however, is variable. The reported period of disappearance of lesion in these studies varied from as low as 6 weeks to as long as 73 Seizure (2006) In this open-label, randomized, prospective, follow-up study, 52 patients with new-onset seizures and a single enhancing CT lesion of cysticercus were randomly divided in two groups to receive either intravenous methyl prednisolone for 5 days along with antiepileptic drug (n = 25) or antiepileptic drug monotherapy (n = 27) alone. The patients were followed up for at least for 9 months. Repeat CT scans were performed after 2 months. Results: After 2 months, lesion disappeared in 60% patients of intravenous methyl prednisolone group and 18.5% patients receiving only antiepileptic drug ( p = 0.001). As far as seizure recurrence was concerned, a lower number (16% versus 33%) of intravenous methyl prednisolone treated patient had recurrence, the difference was insignificant. Conclusion: Intravenous methyl prednisolone therapy helps in early resolution of solitary cysticercus granuloma. # 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. months. 9 Some reports suggest these lesions may persist for a longer duration and cause calcification 7, 8 and perilesional gliosis 10 , which are important risk factors of seizure recurrence. So, an effective intervention is desirable which may help in early and complete resolution of the granuloma. A recent report from our center demonstrates a beneficial effect of short-term prednisolone in resolution of solitary cysticercus granuloma. 11 However, the therapeutic usage of oral prednisolone is associated with potential side effects. The present study was planned to assess the effect of potentially less toxic intravenous methyl prednisolone on resolution of solitary cysticercus granuloma.
Materials and methods
This prospective, randomized and open-label study was conducted between February 2003 and January 2004 in department of Neurology of King George Medical University, Lucknow, India. The institutional ethics committee duly approved the study. A total of 52 consecutive patients of new-onset seizures who had a solitary contrast enhancing CT lesion in brain parenchyma were included in this study. All patients belonged to the North Indian province of Uttar Pradesh, which is highly endemic for infection with Taenia solium and cysticercosis. Clinical and CT criteria given by Rajshekhar and Chandy for solitary cysticercus granuloma were used for inclusion of the patients. These criteria were new-onset seizure (<14 days), no evidence of increased intracranial pressure, no evidence of neurological deficits, no evidence of other systemic illness; CT scan showing a single enhancing CT lesion of less than 20 mm in maximal dimensions 12 ( Fig. 1) . The exclusion criteria were presence of raised intracranial pressure, focal neurological deficits (other than Todd's palsy), intake of anticysticercal treatment in recent past and history of peptic ulcer disease. None of the patients needed to be excluded on the basis of these exclusion criteria.
After informed consent from the patients or from legal guardians (in case of minor), patients were subjected to a detailed systemic and neurological examination. All included patients were subjected to a battery of investigations that included complete blood count, plasma glucose, creatinine, electrolytes and erythrocytes sedimentation rate. The chest was radiographed for possible pulmonary tuberculosis. All patients were subjected to serum enzyme-linked immunosorbent assay (ELISA) for human immunodeficiency virus. Enzyme-linked immunoelectrotransfer blot assay (EITB) and Enzyme-linked immunosorbent assay for Taenia solium were not done due to low sensitivity in case of solitary cysticercus granuloma. 13, 14 All patients were randomly divided into two groups: 25 patients in addition to antiepileptic drugs received 5 days course of intravenous methyl prednisolone in dose of 1.0 g/1.72 m 2 /day (methyl prednisolone group) and the remaining 27 patients received only antiepileptic drug (control group). The randomization was done after inclusion with the help of random number table. All patients were put on single antiepileptic drug therapy (phenytoin or carbamazepine). Initial drug dose was based on body weights. In situations of seizure recurrence or antiepileptic drug toxicity, appropriate dosage adjustments or drug replacements were made. Therapeutic drug monitoring of antiepileptic drug was not performed. None of the patients of either group was treated with anticysticercal drugs. Oral corticosteroids were not given after intravenous methyl prednisolone therapy.
Patients were followed up at monthly interval at least for 9 months. Followed up CT scan were performed in all patients of both groups after 2 months. In the follow-up CT scan, 2 mm cuts of the regions were taken. The lesions were considered ''disappeared'' when follow-up CT scan did not show any lesion.
Intravenous methyl prednisolone in patients with solitary cysticercus granuloma The analysis was done using chi-square test for categorical observations and Students 't'-test to compare continuous observations such as age, onset, number of seizures, and duration of illness between two groups.
Results
No significant difference was seen in any of the epidemiological parameters between the intravenous methyl prednisolone group (25 patients) and the group that received only antiepileptic drug (27 patients). Approximately 80% of the included patients were younger than 20 years. Simple partial seizure with or without secondary generalization was the most common type of seizure. Approximately 60% of patients in each group had more than one seizure. Mean number of seizure at presentation was 2.5 in each group. All included patients had a seizure disorder of 14 days. The mean duration of symptoms was about 8 days. Majority of lesions were located either in frontal or parietal lobes. All patients showed perilesional oedema. More than two third of the enrolled patients had mild perilesional oedema (confined to same cerebral lobe), whereas in the remaining one third perilesional oedema was moderate (affecting the adjacent cerebral lobe as well) ( Table 1) .
Our data suggested that treatment with intravenous methyl prednisolone was associated with significantly better response as far as complete disappearance of solitary cysticercus granuloma was concerned. After 2 months, lesion disappeared in 15 out of 25 (60%) in intravenous methyl prednisolone group and only 5 out of 27 (18.5%) in patients of control group. This difference was statistically significant ( p = 0.001) ( Table 2) . As far as seizure recurrence was concerned, 16% of intravenous methyl prednisolone treated patient and 33% of patients receiving only antiepileptic drugs had recurrence ( p = 0.20) ( Table 3) . Recurrence of seizure was associated with persistence of lesion (either same or reduced in size) in 78% of intravenous methyl prednisolone treated group and 75% in control group (Table 4) .
Eight percent of patients of intravenous methyl prednisolone treated group developed mild pain in abdomen, which responded to antacids. One patient in control group developed rashes in the form of erythema multiforme. In this patient carbamazepine was changed to phenytoin. 15, 16 Possibly antiinflammatory and immunosuppressive properties of intravenous methyl prednisolone on the ongoing inflammatory process in brain parenchyma and cyst wall was also expected to result in early disappearance of granulomatous lesions. In a study by Mall et al. short-term prednisolone therapy was shown to help in rapid resolution of solitary cysticercus granuloma in patients with new-onset seizures. In this study resolution of lesions was associated with improved seizure-related prognosis. 11 Our observations are significant in view of suggestion that the patients with solitary cysticercus granuloma do not require conventional prolonged antiepileptic therapy of 2-3 years once lesion has disappeared. Murthy and Reddy in a retrospective study of 102 patients of solitary cysticercus granuloma have shown that solitary cysticercus granuloma is a benign form of epilepsy and seizure recur as long as the lesion persists. They recommended that antiepileptic drug could safely be withdrawn once the follow-up CTscan shows resolution of these lesions. 9 In our study treatment with intravenous methyl prednisolone helped in complete resolution of cysticercus granuloma. Many authors have shown that recurrence of seizure is more common with persistence of lesion. Pradhan et al. have shown that recurrence of seizure may be due to perilesional gliosis. 10 In another study, Carpio and Hauser in a randomized clinical trial of treatment of patients with active neurocysticercosis observed that treatment with oral prednisolone alone, praziquantel with prednisolone, or albendazole with prednisolone, that at 6 months and at 1 year after treatment, there were no differences in the three treatment groups in terms of the proportion of patients who were free of cysts or the relative reduction of number of cysts. At 2 years, there was no difference in the proportion of patients free of seizures during the entire follow-up period. Early and late sequelae, like such as epilepsy or hydrocephalus, occurred in a higher proportion of patients treated with praziquantel and albendazole, compared with those receiving only prednisolone. 17 In another study by Kalra et al. authors observed that treatment with albendazole and dexamethasone expedited the complete or partial resolution of lesions and also reduced the risk of subsequent seizure recurrence among children. 18 We could not observe expected favorable response of corticosteroids on seizure prognosis. In a recent study similar observation about unfavorable seizure prognosis was also reported with oral prednisolone. Singhi et al. conducted a randomized prospective trial to evaluate the efficacy of corticosteroids, albendazole, and corticosteroids with albendazole in children with solitary cysticercus granuloma. All 110 children were randomly assigned to receive corticosteroids, albendazole, or both corticosteroids and albendazole for 28 days. There was no significant difference in resolution of cysticercus granuloma in the three therapy group. Among 23 patients who had seizure recurrence 36.8% were in corticosteroids group, 13.5% in albendazole group, and 11.4% in which received both. Seizure recurrence after antiepileptic drugs withdrawal was seen in seven children (three in Intravenous methyl prednisolone in patients with solitary cysticercus granuloma 331 corticosteroids group and two each in albendazole group and in group which received both. 19 Possibly, the short-term administration of corticosteroids might have altered the immune equilibrium in patients with cysticercus granuloma leading to rapid but incomplete granuloma resolution. So, possibility of seizure recurrence remained unaffected. We think that there is a need for large controlled trial to further clarify this important finding.
The role of albendazole therapy in patients with neurocysticercosis has been the subject of considerable debate and controversy. Controlled clinical trials have demonstrated that antiparasitic drugs in patients with viable neurocysticercosis lesions can decrease the number of generalized seizures, although the benefit is small and confined to a subgroup of patients. 20 Although some clinicians argue in favor of the routine use of anticysticidal drugs in patients with viable cysticercal lesions and even in those with solitary cysticercus granuloma, others believe that albendazole does not alter seizure outcome in patients with neurocysticercosis. Several authors believe that concurrent administration of dexamethasone in standard doses is usually required during the first several days of antiparasitic therapy to minimize the inflammation and cerebral edema associated with death of the parasites. [20] [21] [22] In our study, we selected only patients with solitary cysticercus granuloma. Our findings would not apply to the patients with multiple viable lesions and patients with extraparenchymal neurocysticercosis.
Antiinflammatory properties of intravenous methyl prednisolone therapy help in early resolution of solitary cysticercus granuloma.
